Therapies for multiple sclerosis targeting B cells

Increasing evidence suggests that B cells contribute both to the regulation of normal autoimmunity and to the pathogenesis of immune mediated diseases, including multiple sclerosis (MS). B cells in MS are skewed toward a pro-inflammatory profile, and contribute to MS pathogenesis by antibody product...

Descripción completa

Detalles Bibliográficos
Autor principal: Milo, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2019
Materias:
International Conference on Neurological Disorders and Neurorestoration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509632/
https://www.ncbi.nlm.nih.gov/pubmed/31044580
http://dx.doi.org/10.3325/cmj.2019.60.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509632/
https://www.ncbi.nlm.nih.gov/pubmed/31044580
http://dx.doi.org/10.3325/cmj.2019.60.87

Ejemplares similares